期刊文献+

硝苯地平联合硫酸镁治疗妊娠期高血压疾病临床疗效观察 被引量:4

Clinical curative effect observation of Nifedipine combined magnesium sulfate in treatment of pregnancy-inducedhypertension disease
原文传递
导出
摘要 目的探讨硝苯地平联合硫酸镁治疗妊娠期高血压的临床效果。方法通过对2012年6月至2016年6月在商丘市妇幼保健院治疗的110例妊娠高血压患者进行随机分组,实验组患者应用硝苯地平联合硫酸镁治疗,对照组患者给予硫酸镁治疗,观察比较两组患者治疗效果、收缩压和舒张压差异。结果实验组患者治疗总有效率为98.18%,明显高于对照组的85.45%;实验组收缩压和舒张压下降程度优于对照组,差异具有统计学意义(P<0.05)。结论妊娠期高血压患者采用硝苯地平联合硫酸镁治疗可明显提高治疗效果,降低血压,其具有安全性高、疗效确切等特点,临床值得推广应用。 Objective To investigate the effect of nifedipine combined of magnesium sulfate in the treatment of pregnancy-induced hypertension. Methods From June 2015 to June 2016 in our hospital treatment of 110 patients with gestational hypertension were randomized,nifedipine combined magnesium sulfate treatment group patients and the control group patients give magnesium sulfate treatment,to observe therapeutic effect compare two groups of patients,the systolic blood pressure and diastolic blood pressure difference. Results The total effective rate of experimental group patients was 98. 18%,significantly higher than the control group 85. 45%; Systolic blood pressure and diastolic blood pressure drop degree is better than that of control group,while statistically significant difference(P〈0. 05). Conclusion Patients with gestational hypertension using nifedipine combined therapy with magnesium sulfate can obviously improve the treatment effect,reduce blood pressure,it has the characteristics of high security,curative effect,clinical worth popularization and application.
作者 刘淑允 LIU shu - yun(Shangqiu Maternity and Child Care Hospital, Shangqiu, Henan 476000, Chin)
出处 《医药论坛杂志》 2017年第1期58-59,共2页 Journal of Medical Forum
关键词 硝苯地平 硫酸镁 妊娠高血压 Nifedipine Magnesium sulfate Gestational hypertension
  • 相关文献

二级参考文献52

  • 1窦金玲.硫酸镁联合拉贝洛尔治疗妊娠期高血压的临床观察[J].中外医疗,2012,31(28):100-100. 被引量:21
  • 2乐杰.妇产科学[M].北京:人民卫生出版社,2011:295-298.
  • 3乐杰.妇产科学[M].6版.北京:人民卫生出版社,2005:145.
  • 4Xiao C, Gangal M, Abenhaim H A.Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births[J].J Perinat Med, 2014, 42(5): 585-589.
  • 5Prakash J, Vohra R, Pandey L K, et al.Spectrum of kidney diseases in patients with preeclampsia-eclampsia[J].J Assoc Physicians India, 2010, 9(58): 543-546.
  • 6Dhali B, Bhattacharya S, Ganguly R P, et al.A randomized trial of intravenous labetalol & oral nifedipine in severe pregnancy induced hypertension[J].Int J Reprod Contraeept Obstet Gynecol, 2012, 1(1): 42-46.
  • 7Poon L C, Kametas N A, Chelemen T, et al.Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach[J].J Hum Hypertens, 2010, 24(2): 104-110.
  • 8Ankichetty S P, Chin K J, Chan Y W, et al.Regional anesthesia in patients with pregnancy induced hypertension[J].J Anaesthesiol Clin Pharmacol, 2013, 29(4): 435-444,.
  • 9Acquah L, Garovic V D.Hypertension and Pregnaucy[M].Evidence-Based Cardiology Consult: Springer London, 2014 : 433-442.
  • 10谢志红,苏海,张倩萍,龚艺,李菊香.妊娠高血压综合征患者远期高血压患病率的调查[J].中华高血压杂志,2008,16(3):261-263. 被引量:19

共引文献180

同被引文献21

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部